RX
RxSight, Inc.
RXST · NASDAQ
$5.96 -4.79% (-$0.30)
1M -15.58%
Market Cap $246.7M
P/E Ratio -
Div. Yield -
ROE 17.35%
Bulios Fair Price
$5.14
13.8% downside
Trenutna cena
$5.96
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RXST trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
88 /100
Cheap P/S 1.93x
P/B 0.94x
P/E N/A
Growth
100 /100
Growing Rev. growth 40.00%
Book val. growth 45.28%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 77.50%
FCF margin 21.29%
Net margin 36.80%
Quality
5 /100
Poor ROIC 20.17%
Asset turnover 0.36x
ROE 17.35%
Debt
69 /100
Low Debt/Equity 0.04x
Int. coverage -3,121.60x
Current ratio 4.07x
Stability
30 /100
Unstable Beta 1.16x
Profitable years 0
Rev. volatility 44.10%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RXST
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Aziz Mottiwala
Employees
461
Headquarters
Aliso Viejo
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report